CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Triple Combination Therapy Using Metformin, Thiazolidinedione, and a GLP-1 Analog or DPP-IV Inhibitor in Patients with Type 2 Diabetes Mellitus
Sun Woo Kim
Diabetes Metab J. 2010;34(6):331-337.   Published online December 31, 2010
DOI: https://doi.org/10.4093/kdj.2010.34.6.331

Excel Download

Triple Combination Therapy Using Metformin, Thiazolidinedione, and a GLP-1 Analog or DPP-IV Inhibitor in Patients with Type 2 Diabetes Mellitus
Korean Diabetes Journal. 2010;34(6):331   Crossref logo
Link1 Link2 Link3

Second line therapy: type 2 diabetic subjects failing on metformin GLP-1/DPP-IV inhibitorsversussulphonylurea/insulin: For GLP-1/DPP-IV inhibitors
Diabetes/Metabolism Research and Reviews. 2012;28:21-25   Crossref logo
Link1 Link2

Patient preference and tolerability of a DPP-4 inhibitor versus a GLP-1 analog in patients with type 2 diabetes mellitus inadequately controlled with metformin: a 24-week, randomized, multicenter, crossover study
Therapeutic Advances in Endocrinology and Metabolism. 2015;6(4):141-148   Crossref logo
Link1 Link2 Link3

Evaluation of glycemic control by metformin + glitazone + DPP-4 inhibitor + SGLT-2 inhibitor combination in patients with type 2 diabetes quitting basal/bolus insulin therapy
Medicine Science | International Medical Journal. 2019;1   Crossref logo
Link1

To investigate the efficacy of dipeptidyl peptidase-IV (DPP-IV) inhibitor therapy in multiethnic Asian patients with type 2 diabetes mellitus
Diabetes Research and Clinical Practice. 2016;120:S123-S124   Crossref logo
Link1 Link2

Efficacy and Safety of Switching From the DPP-4 Inhibitor Sitagliptin to the Human GLP-1 Analog Liraglutide After 52 Weeks in Metformin-Treated Patients With Type 2 Diabetes
Diabetes Care. 2012;35(10):1986-1993   Crossref logo
Link1 Link2

GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors
Current Diabetes Reports. 2007;7(5):340-347   Crossref logo
Link1 Link2 Link3

1275-P: Cost Effectiveness of Using DPP-4i and SGLT2i Combination Therapy vs. Switching to GLP-1 Therapy for the Management of Type 2 Diabetes
Diabetes. 2019;68(Supplement_1):   Crossref logo
Link1 Link2

Beyond Metformin: Initiating Combination Therapy in Patients with Type 2 Diabetes Mellitus
Pharmacotherapy. 2011;31(12S):44S-53S   Crossref logo
Link1 Link2

Medium-Term Effect of Add-On Therapy with the DPP-4 Inhibitor, Sitagliptin, in Insulin-Treated Japanese Patients with Type 2 Diabetes Mellitus
Diabetes Therapy. 2016;7(2):309-320   Crossref logo
Link1 Link2 Link3 Link4